Company

Axovia Therapeutics

Biotechnology Research London, City of, United Kingdom 9 employees

Employees: 9
Contacts: 3
Emails: 3

axoviatherapeutics.com LinkedIn Crunchbase

Axovia Therapeutics Overview

Headquarters: London, City of, United Kingdom
Website: axoviatherapeutics.com
Industry: Biotechnology Research
Employees: 9
Funding: 1.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Axovia Therapeutics

Axovia Therapeutics is dedicated to the research and development of novel AAV gene therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families and caregivers. Axovia is currently developing therapies for patients with mutations in the BBS1 gene which manifests as Bardet Biedl Syndrome. Our initial goal is to halt the progression of BBS by targeting the most debilitating aspects of the neurological, metabolic and retinal dysfunctions.

Axovia Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Axovia Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Marian Seda	Research Manager at Axovia Therapeutics	London, England, United Kingdom	Email
Victor Hernandez	Cso, Axovia Therapeutics Lecturer	Camden Town, England, United Kingdom	Email
Jeshmi Jeyabalan Srikaran		Greater London, England, United Kingdom	View
Charmaine O'neill	Vice President Clinical Operations	London, England, United Kingdom	Email